ADIPOQ and type 2 diabetes mellitus: Obesity, metabolic syndrome and type 2 diabetes are associated with an inflammatory pattern characterized by the overexpression of pro-inflammatory cytokines and a reduced production of adiponectin, a protective factor, suggesting a close relationship between these biomarkers, metabolic disorders and cardiovascular risk [32].